Long-Term Efficacy of Induction Therapy With Anti–Interleukin-2 Receptor Antibodies or Thymoglobulin Compared With No Induction Therapy in Renal Transplantation-Reference-Cited by-同舟云学术

Long-Term Efficacy of Induction Therapy With Anti–Interleukin-2 Receptor Antibodies or Thymoglobulin Compared With No Induction Therapy in Renal Transplantation

Published:2008-12 Issue:10 Volume:40 Page:3401-3407
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Taber D.J.,Weimert N.A.,Henderson F.,Lin A.,Bratton C.F.,Chavin K.D.,Baliga P.K.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference17 articles.

1. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids;Mourad;Transplantation,2004

2. Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial;Sheashaa;J Nephrol,2003

3. Antibody induction therapy in renal transplant patients receiving calcineurin- inhibitor immunosuppressive regimens: a comparative review;Nashan;Biodrugs,2005

4. Clinical transplants;Bunnapradist,2003

5. Rabbit antithymocyte globulin versus basiliximab in renal transplantation;Brennan;N Engl J Med,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of lymphocyte-depleting antibodies in specific populations of kidney transplant recipients: A systematic review and meta-analysis;Transplantation Reviews;2023-12

2. Progress in kidney transplantation: The role for systems immunology;Frontiers in Medicine;2022-12-16

3. Safety and Efficacy of Induction Therapy With Thymoglobulin in AB0-Incompatible Kidney Transplantation;Transplantation Proceedings;2018-01

4. Kidney transplant after hematopoietic cell transplant in pediatrics: Infectious and immunosuppressive considerations;Pediatric Transplantation;2017-04-27

5. Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience;International Urology and Nephrology;2016-05-11